PULMONX CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
PULMONX CORPORATION (LUNG) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $16.54 per share as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $16.54.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $16.73.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $15.72.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $14.45.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $16.54 10-Q · filed 2026-08-04 |
| 2026-03-31 | $16.73 10-Q · filed 2026-05-04 |
| 2025-12-31 | $15.72 10-K · filed 2026-03-10 |
| 2025-09-30 | $14.45 10-Q · filed 2025-11-12 |
| 2025-06-30 | $14.44 10-Q · filed 2025-08-01 |
| 2025-03-31 | $14.36 10-Q · filed 2025-05-02 |
| 2024-12-31 | $14.42 10-K · filed 2025-02-25 |
| 2024-09-30 | $14.47 10-Q · filed 2024-11-01 |
| 2024-06-30 | $14.48 10-Q · filed 2024-08-02 |
| 2024-03-31 | $15.14 10-Q · filed 2024-05-03 |
| 2023-12-31 | $16.40 10-K · filed 2024-02-27 |
| 2023-09-30 | $16.28 10-Q · filed 2023-11-03 |
| 2023-06-30 | $16.20 10-Q · filed 2023-08-04 |
| 2023-03-31 | $15.97 10-Q · filed 2023-05-08 |
| 2022-12-31 | $17.35 10-K · filed 2023-03-01 |
| 2022-09-30 | $17.25 10-Q · filed 2022-11-08 |
| 2022-06-30 | $17.43 10-Q · filed 2022-08-08 |
| 2022-03-31 | $17.00 10-Q · filed 2022-05-09 |
| 2021-12-31 | $13.44 10-K · filed 2022-03-01 |
| 2021-09-30 | $12.96 10-Q · filed 2021-11-09 |
| 2021-06-30 | $12.04 10-Q · filed 2021-08-10 |
| 2021-03-31 | $5.05 10-Q · filed 2021-05-12 |
| 2020-12-31 | $4.72 10-K · filed 2021-03-15 |
| 2020-09-30 | $3.94 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |